About the
Event
19th Edwaldo Camargo Symposium
It is with great enthusiasm that we announce the joint holding of the 13th International Symposium of Targeted Alpha Therapy (TAT 13) with the 19th edition of the Edwaldo Camargo Symposium, both scheduled for April 2026, in Rio de Janeiro.
Consolidated as the second largest Nuclear Medicine meeting in Brazil, the Edwaldo Camargo Symposium reaches its 19th edition. This year the Edwaldo Camargo Symposium will focus on Beta Therapy with clinical multidisciplinary sessions held on April 14-15, 2026. April 16 will feature a clinical day of TAT13.
The convergence of these two Symposia opens space for a rich exchange of knowledge, articulates different fronts of Nuclear Medicine and stimulates collaborative initiatives, both in the national and international scenario, focusing on the most current innovations in oncology diagnostics and therapies.
An unparalleled scientific and cultural experience
Join us in Rio de Janeiro and be inspired by these two Symposia surrounded by emblematic landscapes and a wide range of cultural offerings.
Follow our official channels for more information on dates, schedule and registration.
We look forward to seeing you here!
Organizing Committee
TAT 13th and 19th Edwaldo Camargo Symposium
-
TAT 13 International Symposium and 19th Edwaldo Camargo Symposium in:
-
00Days
- :
-
00Hours
- :
-
00Minutes.
- :
-
00Seconds.